The combined detection of Amphiregulin, Cyclin A1 and DDX20/Gemin3 expression predicts aggressive forms of oral squamous cell carcinoma
British Journal of Cancer, 2021•nature.com
Background Large-scale genetic and epigenetic deregulations enable cancer cells to
ectopically activate tissue-specific expression programmes. A specifically designed strategy
was applied to oral squamous cell carcinomas (OSCC) in order to detect ectopic gene
activations and develop a prognostic stratification test. Methods A dedicated original
prognosis biomarker discovery approach was implemented using genome-wide
transcriptomic data of OSCC, including training and validation cohorts. Abnormal …
ectopically activate tissue-specific expression programmes. A specifically designed strategy
was applied to oral squamous cell carcinomas (OSCC) in order to detect ectopic gene
activations and develop a prognostic stratification test. Methods A dedicated original
prognosis biomarker discovery approach was implemented using genome-wide
transcriptomic data of OSCC, including training and validation cohorts. Abnormal …
Background
Large-scale genetic and epigenetic deregulations enable cancer cells to ectopically activate tissue-specific expression programmes. A specifically designed strategy was applied to oral squamous cell carcinomas (OSCC) in order to detect ectopic gene activations and develop a prognostic stratification test.
Methods
A dedicated original prognosis biomarker discovery approach was implemented using genome-wide transcriptomic data of OSCC, including training and validation cohorts. Abnormal expressions of silent genes were systematically detected, correlated with survival probabilities and evaluated as predictive biomarkers. The resulting stratification test was confirmed in an independent cohort using immunohistochemistry.
Results
A specific gene expression signature, including a combination of three genes, AREG, CCNA1 and DDX20, was found associated with high-risk OSCC in univariate and multivariate analyses. It was translated into an immunohistochemistry-based test, which successfully stratified patients of our own independent cohort.
Discussion
The exploration of the whole gene expression profile characterising aggressive OSCC tumours highlights their enhanced proliferative and poorly differentiated intrinsic nature. Experimental targeting of CCNA1 in OSCC cells is associated with a shift of transcriptomic signature towards the less aggressive form of OSCC, suggesting that CCNA1 could be a good target for therapeutic approaches.
nature.com
以上显示的是最相近的搜索结果。 查看全部搜索结果